Certara logo

CertaraNASDAQ: CERT

Profile

Sector:

Healthcare

Country:

United States

IPO:

11 December 2020

Next earnings report:

28 February 2025

Last dividends:

N/A

Next dividends:

N/A
$1.58 B
-67%vs. 3y high
78%vs. sector
-vs. 3y high
-vs. sector
-70%vs. 3y high
49%vs. sector
-76%vs. 3y high
58%vs. sector

Price

after hours | Wed, 20 Nov 2024 23:13:00 GMT
$9.81+$0.01(+0.10%)

Dividend

No data over the past 3 years
$94.82 M$98.26 M
$94.82 M-$1.37 M

Analysts recommendations

Institutional Ownership

CERT Latest News

Certara Reports Third Quarter 2024 Financial Results
globenewswire.com06 November 2024 Sentiment: POSITIVE

RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2024.

Certara Appoints John Reynders as New Independent Board Member
globenewswire.com16 October 2024 Sentiment: POSITIVE

RADNOR, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of John Reynders, PhD, to its Board of Directors, effective October 15, 2024.

Certara Completes Acquisition of Chemaxon
globenewswire.com02 October 2024 Sentiment: POSITIVE

Certara completes acquiring Chemaxon, a leading cheminformatics company that develops scientific informatics software used by the life sciences industry.

Certara to Participate in Upcoming Investor Conferences
globenewswire.com21 August 2024 Sentiment: POSITIVE

RADNOR, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

Certara Launches Phoenix™ Version 8.5 Drug Development Software
globenewswire.com15 August 2024 Sentiment: POSITIVE

RADNOR, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Phoenix™ version 8.5.

Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates
zacks.com06 August 2024 Sentiment: NEGATIVE

Certara, Inc. (CERT) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.12 per share a year ago.

Certara Reports Second Quarter 2024 Financial Results
globenewswire.com06 August 2024 Sentiment: POSITIVE

RADNOR, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2024.

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
globenewswire.com09 July 2024 Sentiment: POSITIVE

Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software.

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
globenewswire.com02 July 2024 Sentiment: POSITIVE

RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2024 after the market close on Tuesday, August 6th, 2024. Company management will host a conference call to discuss financial results at 5:00PM ET.

Certara to Participate in the Jefferies Global Healthcare Conference
globenewswire.com29 May 2024 Sentiment: POSITIVE

RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Healthcare Conference.

  • 1(current)

What type of business is Certara?

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

What sector is Certara in?

Certara is in the Healthcare sector

What industry is Certara in?

Certara is in the Health Information Services industry

What country is Certara from?

Certara is headquartered in United States

When did Certara go public?

Certara initial public offering (IPO) was on 11 December 2020

What is Certara website?

https://www.certara.com

Is Certara in the S&P 500?

No, Certara is not included in the S&P 500 index

Is Certara in the NASDAQ 100?

No, Certara is not included in the NASDAQ 100 index

Is Certara in the Dow Jones?

No, Certara is not included in the Dow Jones index

When was Certara the previous earnings report?

No data

When does Certara earnings report?

The next expected earnings date for Certara is 28 February 2025